κ-Opioid receptor stimulation inhibits augmentation of Ca2+ transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIδB

European Journal of Pharmacology

Volumn 595, Issue 1-3, 2008, Pages 52-57

  Wu, Guoqiang ^a   Wang, Hongxin ^a   Yang, Jing ^a   Yang, Yuhong ^a   Liu, Chunna ^a   Jing, Li ^a   Wong, Tak Ming ^b  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Opioid receptor; Ca2+; CaMKII ; Cardiac hypertrophy; Isoprenaline; Neonatal ventricular myocyte; U50,488H

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; CALMODULIN INHIBITOR; CALMODULIN KINASE II INHIBITOR; CALMODULIN KINASE II SIGMAB; FURA 2 ACETOXYMETHYL ESTER; ISOPRENALINE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; LEUCINE; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; NORBINALTORPHIMINE; PROPRANOLOL; PROTEIN KINASE (CALCIUM,CALMODULIN) II; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; ENZYME MECHANISM; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; RECEPTOR UPREGULATION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANIMALS, NEWBORN; BENZYLAMINES; CALCIUM CHANNEL BLOCKERS; CALCIUM SIGNALING; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL NUCLEUS; CELL SIZE; CELLS, CULTURED; HYPERTROPHY; ISOPROTERENOL; MYOCYTES, CARDIAC; NALTREXONE; NARCOTIC ANTAGONISTS; PROPRANOLOL; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, OPIOID, KAPPA; SULFONAMIDES; VERAPAMIL;

EID: 52149111365     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.07.059     Document Type: Article

References (43)

1. Amjid A.R., Wang Y.S., Rene S., Tohru S., and Michael D.M. Role of angiotensin II in ischemia/reperfusion-induced leukocyte-endothelium interactions in the colon. FASEB J. 10 (2004) 1096-1118
2. Berk B.C., Vekshtein V., Gordon H.M., and Tsuda T. AngII-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 13 (1989) 305-314
3. Campell D.L., and Strauss H.C. Regulation of calcium channels in the heart. Adv. Second Messenger Phosphoprot. Res. 30 (1995) 25-88
4. 1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction. Am. J. Physiol, Heart Circ. Physiol. 291 (2006) 1299-1308
5. Carmine M., David Z., Gianluigi C., Philip T., Stephen F., and Junichi S. The Akt-glycogen synthase kinase 3b pathway regulates transcription of atrial natriuretic factor induced by b-adrenergic receptor stimulation in cardiac myocytes. J. Biol. Chem. 275 (2000) 14466-14475
6. Gruver C.L., DeMayo F., Goldstein M.A., and Means A.R. Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice. Endocrinology 133 (1993) 376-388
7. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260 (1985) 3340-3350
8. Irons C.E., Sei C.A., Hidaka H., and Glembotski C.C. Protein kinases C and calmodulin kinase are required for endothelin-stimulated atrial natriuretic factor secretion from primary atrial myocytes. J. Biol. Chem. 267 (1992) 5122-5216
9. Karliner J.S., Kariya T., and Simpson P.C. Effect of pertussis toxin on a1-agonist-mediated phosphatidylinositide turnover and myocardial cell hypertrophy in neonatal rat myocytes. Experientia 46 (1990) 61-84
10. LaPointe M.C., Deschepper C.F., Wu J.P., and Gardner D.G. Extracellular calcium regulates expression of the gene for atrial natriuretic factor. Hypertension 15 (1990) 20-28
11. Leite M.F., Page E., and Ambler S.K. Regulation of ANP secretion by endothelin-1 in cultured atrial myocytes: desensitization and receptor subtype. Am. J. Physiol. 267 (1994) 2163-2203
12. Liang B.T. Protein kinase C-mediated preconditioning of cardiac myocytes: role of adenosine receptor and KATP channel. Am. J. Physiol. 273 (1997) 847-853
13. Lowry O.H., Rosebrough N.J., and Farr A.L. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
14. Luo J.D., Xie F., Zhang W.W., Ma X.D., and Guan J.X. Simvastatin inhibits noradrenaline-induced hypertrophy of cultured neonatal rat cardiomyocytes. Br. J. Pharmacol. 132 (2001) 159-164
15. Maclennan D.H., and Kranias E.G. Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell Biol. 4 (2003) 566-577
16. McDonough P.M., Stella S.L., and Glembotski C.C. Involvement of cytoplasmic calcium and protein kinases in the regulation of atrial natriuretic factor secretion by contraction rate and endothelin. J. Biol. Chem. 269 (1994) 9466-9472
17. Min W., Michiko T., and Joshua R.B. Regulation of L-type calcium current by intracellular magnesium in rat cardiac myocytes. J. Physiol. 555 (2003) 383-396
18. Miura T., Miura T., Kawamura S., Goto M., Sakamoto J., Tsuchida A., Matsuzaki M., and Shimamoto K. Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes. Cardiovasc. Res. 37 (1998) 700-709
19. Nagy N., Shiroto K., Malik G., Huang C.K., Gaestel M., and Abdellatif M. Ischemic preconditioning involves dual cardio-protective axes with p38MAPK as upstream target. J. Mol. Cell. Cardiol. 42 (2007) 981-990
20. Portoghese P.S., Lipkowski A.W., and Takemori A.E. Binaltorphimine and nor-binaltorphimine, potent and selective k-opioid receptor antagonists. Life Sci. 40 (1987) 1287-1292
21. Rorabaugh B.R., Ross S.A., Gaivin R.J., Papay R.S., and McCune D.F. Alpha1A- but not alpha1B-adrenergic receptors precondition the ischemic heart by a staurosporine-sensitive, chelerythrine-insensitive mechanism. Cardiovasc. Res. 65 (2005) 436-445
22. Rothman R.B., Bykov V., DeCosta B.R., Jacobson A.B., Rice K.C., and Brandy L.S. Interaction of endogenous opioid sites in guinea pig brain. Peptides 11 (1990) 311
23. Sadoshima J., Xu Y., Slayter H.S., and Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75 (1993) 977-984
24. Sei C.A. The a-adrenergic stimulation of atrial natriuretic factor expression in cardiac myocytes requires calcium influx, protein kinase C, and calmodulin-regulated pathways. J. Biol. Chem. 266 (1991) 15910-15916
25. Shan J., Yu X.C., Fung M.L., and Wong T.M. Attenuated "cross talk" between k-opioid receptors and beta-adrenoceptors in the heart of chronically hypoxic rats. Pflugers Arch. 444 (2002) 126-132
26. 1-adrenoceptor stimulation in the rat. Eur. J. Pharmacol. 555 (2007) 100-105
27. 2+ elevations evoked by k-opioid receptor in rat myocytes. Eur. J. Pharmacol. 307 (1996) 323-329
28. i in myocytes. Am. J. Physiol. (Cell Physiol) 272 41 (1997) 560-564
29. Simpson P., and Savion S. Differentiation of rat myocytes in single cell cultures with and without proliferation nonmyocardial cells. Cross-striations, ultrastructure, and chromotropic response to isoproterenol. Circ. Res. 50 (1982) 101-116
30. Sonnenberg H. Mechanisms of release and renal tubular action of atrial natriuresis factors. Fed. Proc. 45 (1986) 2106-2110
31. Tai K.K., Blan C.F., and Wong T.M. Kappa-opioid receptor stimulation increases intracellular free calcium in isolated rat ventricular myocytes. Life Sci. 51 (1992) 909-913
32. Takemori A.E., Ho B.Y., Naeseth J.S., and Portoghese P.S. Nor-binaltorphimine, a highly selective k-opioid antagonist in analgesic and receptor binding assays. J. Pharmacol. Exp. Ther. 246 (1988) 255-258
33. Tortilla F.C., Echevarria E., Lipkowski A.W., Takemori A.E., Portoghese P.S., and Holanday J.W. Selective kappa antagonist properties of nor-binaltorphimine in the rat MES seizure model. Life Sci. 44 (1989) 661-665
34. 2+ release from an intracellular pool in myocytes and neurons. Circ. Res. 70 (1992) 66-81
35. Wang H.X., Tao L., and Rao M.R. Inhibitory effects of captopril on protein synthesis of cultured neonatal rat heart cells. Chin. J. Pharmacol. Toxicol. 9 (1995) 8-11
36. Wang G.J., Wang H.X., Yang Y.H., and Wong T.M. Kappa-opioid receptor stimulation inhibits growth of neonatal rat ventricular myocytes. Eur. J. Pharmacol. 13 (2004) 53-58
37. Yu X.C., Li H.Y., Wang H.X., and Wong T.M. U50,488H inhibits effects of norepinephrine in rat cardiomyocytes-cross talk between k-opioid and b-adrenergic receptors. J. Mol. Cell. Cardiol. 30 (1998) 405-413
38. Yu X.C., Wang H.X., Pei J.M., and Wong T.M. Anti-arrhythmic action of U50,488H in the isolated perfused rat heart subjected to low flow and norepinephrine-involvement of a cAMP dependent pathway. J. Mol. Cell. Cardiol. 31 (1999) 1809-1819
39. Yu X.C., Diao T.M., Pei J.M., Zhang W.M., Wong N.S., and Wong T.M. k-Opioid receptor agonist inhibits the cholera toxin sensitive G-protein in the heart. J. Cardiovasc. Pharmacol. 38 (2001) 232-239
40. 2+/calmodulin-dependent protein kinase II induces hypertrophy and dilated cardiomyopathy associated with increased protein phosphatase 2A activity. J. Biol. Chem. 277 (2002) 1261-1267
41. Zheng J.S., Boluyt M.O., Long X., O, 'Neil L., Lakatta E.G., and Crow M.T. Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of neonatal cardiac myocytes. Circ. Res. 78 (1996) 525-535
42. Zheng M., Han Q.D., and Xiao R.P. Distinct b-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance. Acta Physiol. Sin. 56 (2004) 1-15
43. 2-opioid receptors. Proc. Natl. Acad. Sci. 85 (1988) 4601-4605